A bone marrow transplant and cellular therapy programme at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center in Dallas, established in 1998.
According to its website, UT Southwestern Medical Center operates a bone marrow transplant (also called stem cell transplant) programme within the Harold C. Simmons Comprehensive Cancer Center in Dallas, Texas, which the site describes as the only cancer centre in North Texas holding the National Cancer Institute's comprehensive designation. The site states the transplant programme was established in 1998 and has completed approximately 2,500 bone marrow transplants and more than 300 chimeric antigen receptor (CAR) T-cell infusions — a treatment in which a patient's own immune cells are modified to target cancer.
The site describes both autologous transplants, using the patient's own stem cells, and allogeneic transplants, using cells from a matched sibling, an unrelated volunteer donor, a partially matched family member, or umbilical cord blood. Conditions listed include cancers such as leukaemia, Hodgkin and non-Hodgkin lymphoma, multiple myeloma and myelodysplastic syndromes, as well as non-cancerous conditions including aplastic anaemia, severe immune deficiency disorders, sickle cell disease, thalassaemia, and certain inherited blood diseases and metabolic disorders. The programme also offers CAR T-cell therapy, including allogeneic versions in clinical trials, total marrow and lymphoid irradiation as a treatment option, and a survivorship clinic for adolescent and young adult patients. A related paediatric bone marrow transplant programme operates at Children's Medical Center Dallas.
The site states the programme is accredited by the Foundation for the Accreditation of Cellular Therapy and is recognised as a national centre of excellence by major health insurance carriers, though it gives no specific pricing information. No individual clinicians are named with credentials on the pages reviewed.
The site describes both autologous transplants, using the patient's own stem cells, and allogeneic transplants, using donor cells, as part of this programme.
No individual clinicians are named with credentials on the pages reviewed.
The programme is based at the Blood Cancers/Transplant and Cellular Therapies Clinic within the Cancer Care Outpatient Building on UT Southwestern's Dallas campus, with inpatient care provided at William P. Clements Jr. University Hospital. It is part of the Harold C. Simmons Comprehensive Cancer Center, described on the site as the only National Cancer Institute-designated comprehensive cancer centre in North Texas.
The site does not publish specific prices. It states the programme is recognised as a national centre of excellence by major health insurance carriers, but a patient would need to confirm coverage and cost directly with the centre and their insurer.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.